Abstract There has been continuous debate regarding the applicability of various composite measures for the assessment of disease activity in rheumatoid arthritis (RA). In order to further dissect this issue, we numerically and graphically modeled 28-joint disease activity scale (DAS28), simplified disease activity index (SDAI), and clinical disease activity index (CDAI) by three-dimensional (3D) plotting. We wished to graphically visualize the relative contribution of various elements in the three activity indices to each other. We calculated DAS28 (3 variables), SDAI, and CDAI by the standard equations. We plotted 3D "carpets" showing all combinations of the corresponding variables yielding to DAS28 =5.1, DAS28 = 3.2, DAS28 = 2.6, SDAI = 26, SDAI = 11, and SDAI=3.3. We also plotted the 3D carpet for CDAI. In patients with high or moderate disease activity, erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) was not a major confounding factor when calculating DAS28 and SDAI, respectively. In contrast, ESR and CRP highly overshadowed changes in joint counts and global assessments in patients with low disease activity (LDA) or those in remission. No reliable assessment of LDA can be performed in cases where ESR >54 mm/h or CRP >20 mg/dl. Similarly, remission cannot be determined if ESR >19 mm/h or CRP >5 mg/dl. As CDAI does not include acute phase reactants, CDAI may be a useful tool even in states of remission or LDA. Our results suggest that acute phase reactants are indeed major confounding factors and should be omitted when assessing RA disease activity at least in special cases.
Introduction
Rheumatoid arthritis (RA) is a progressive inflammatory rheumatic disease, which may lead to joint destruction and disability. Thus, early diagnosis, close follow-up, and early, effective treatment are imperative in order to prevent structural damage and functional impairment [1, 2] . Various instruments have been developed in order to accurately determine disease activity of RA at any given time point during the disease course [2] . Among disease activity indices, the 28-joint disease activity scale (DAS28) has long been used in the daily practice, as well as in clinical trials. The 3-variable DAS28 (DAS28-V3) includes erythrocyte sedimentation rate (ESR), swollen (SJC), and tender joint counts (TJC) determined in 28 designated joints, while the 4-variable version (DAS28-V4) also includes patient-determined global health (GH) assessed on a 100-mm visual analogue scale (VAS) [2] [3] [4] . However, the somewhat complicated formula requires the use of special calculators or computer softwares (Table 1) . Therefore, a simplified disease activity index (SDAI) has later been developed by simply adding five variables including SJC, TJC in 28 joints, C-reactive protein level (CRP, mg/dL), as well as patient-(PGA) and evaluator-determined global disease activity (EGA) assessed by 10-cm VAS [5] [6] [7] . Some further studies suggested that the determination of acute phase reactants (APR), such as ESR or CRP add little to the other four parameters when assessing SDAI [8] . Therefore, an even more simple clinical disease activity index (CDAI) has been introduced by omitting CRP and just adding the other four variables, SJC, TJC, PGA, and EGA [5, 6, 9] . The elements of these composite indices and the calculation formulas are included in Table 1 .
It has become clear from routine clinical practice that the "APR issue" may have another important aspect. Apart from not giving extra value during the determination of disease activity [8] , ESR and CRP may even overshadow the other clinical parameters. Indeed, APRs reflect systemic inflammation and, in most patients, reflect disease activity. However, we often see patients with low disease activity (LDA) of RA, yet highly elevated ESR or CRP levels due to other confounding factors, such as infections, paraproteins, or simply high immunoglobulin or total protein levels. On the other hand, some patients may have highly destructive RA despite "low-grade" inflammation. In such conditions, very low or very high APR levels may override the influence of other clinical variables when determining DAS28 or SDAI. As very recently published by Smolen and Aletaha [10] , the determination of response to biologics may be highly influenced by APRs as much better response to tocilizumab was observed using DAS28 in comparison to CDAI.
In order to further dissect this issue, we numerically and graphically modeled DAS28, SDAI, and CDAI by threedimensional (3D) plotting. Our aim was to compare and graphically visualize the relative contribution of various elements in the three activity indices to each other. Our results suggest that APRs are indeed major confounding factors and should be omitted when assessing RA disease activity at least in special cases. 
DAS28-V3 graphs
We used the 3-variable version of DAS28. DAS28-V3 was c a l c u l a t e d b y u s i n g t h e s t a n d a r d e q u a t i o n o f DAS28=(0.56×√¯TJC+0.28×√¯SJC+0.7×ln ESR)×1.08+ 0.16. According to the definition of high, low disease activity and remission (Table 1) , DAS28=5.1, 3.2, and 2.6, respectively, were calculated using all possible TJC (0-28), SJC (0-28), and ESR (0-100 mm/h) values. Then, 3D graphs were plotted with TJC, ESR, and SJC on the X-, Y-, and Z-axes, respectively, expressing DAS28 values of 5.1 (Fig. 1a-c ), 3.2 ( Fig. 2a-c) , and 2.6 ( Fig. 3-c) . Three-dimensional "carpets" are presented as snapshots taken from different views.
SDAI graphs
SDAI was calculated by the standard equation of SDAI = TJC + SJC + PGA + EGA + CRP, assessing 28-jount counts (Table 1) . As five variables cannot be plotted in 3D graphs, TJC and SJC were added yielding to a composite joint score (TJC + SJC, 0-56), PGA and EGA were also added yielding to a composite assessment score (PGA + EGA: 0-20), and these two composite scores were plotted against CRP. Now, we ended up with only three variables. As the SDAI limits between high/moderate, moderate/LDA, and LDA/remission are 26, 11, and 3.3, respectively (Table 1) , we plotted three 3D graphs expressing SDAI values of 26 (Fig. 4), 11 (Fig. 5) , and 3.3 (Fig. 6 ). In these carpets, TJC + SJC, CRP and PGA + EGA were plotted on the X-, Y-, and Z-axes, respectively.
CDAI graphs
CDAI was calculated by the standard formula of CDAI = TJC + SJC + PGA + EGA by assessing 28 joints ( yielded to only two variables; so in this situation, TJC + SJC and PGA + EGA were plotted on X-and Z-axes, and all CDAI values could be visualized in on the Y-axis of 3D carpets (Fig. 7a, b) .
Results

The DAS28 carpets
In Figs. 1, 2 , and 3, carpets of DAS28=5.1, 3.2, and 2.6 are visualized as snapshots taken from three different views (A, B, and C), respectively. The DAS28=5.1 carpet (Fig. 1a-c (Fig. 2a-c) , it is clear from the examples that zero TJC and SJC correspond with ESR=54 mm/h. Thus, patients with ESR >54 mm/h may never reach LDA. As some patients may exert higher ESR despite of no or very few tender and swollen joints, ESR may be a confounding factor when calculating DAS28 and may override the weight of the other two variables.
Similarly, when the carpet of DAS28=2.6 is visualized (Fig. 3a-c) , zero TJC and SJC correspond with ESR = 19 mm/h. Thus, RA patients with ESR >19 mm/h would never reach the state of remission.
The SDAI carpets
In Figs. 4, 5, and 6, carpets of SDAI=26, SDAI=11, and SDAI=3.3 are visualized as snapshots, respectively. The SDAI=26 carpet (Fig. 4) reflects all possibilities, how high disease activity can be reached. If SJC + TJC or PGA + EGA sums are below 26, CRP is positive. In the case of cutoff between moderate and low disease activity (SDAI=11), most of the carpet is "on the floor," only TJC + SJC or PGA + EGA that sums below 11 would yield positive CRP values (Fig. 5) . As for remission (SDAI=3.3), CRP must be 3.3 mg/dl or lower that yields to an almost flat graph. Both the TJC + SJC and the PGA + EGA sums must be <3, otherwise CRP would yield a negative value (Fig. 6) . Thus, in the case of relatively high joint and/or assessment scores (>26), high disease activity can easily be reached, irrespective of CRP (Fig. 4) . In contrast, when the carpets of SDAI=11 and SDAI=3.3 are plotted (Figs. 5 and 6 ), almost the whole carpet is on the floor. In these cases, CRP cannot be more than 11 or 3.3 mg/dl, respectively, otherwise CRP would be a confounding factor when calculating SDAI and may override the weight of the other four variables. In other words, patients with CRP >11 mg/dl or with CRP >3.3 mg/dl could never show SDAI-determined LDA or remission, respectively (Figs. 5 and 6 ).
The CDAI carpets
In Fig. 7a, b , CDAI values are plotted on the Y-axis against composite joint (X-axis) and assessment scores (Z-axis) formed similarly to SDAI visualization. CDAI carpets are visualized as snapshots taken from two different views (A and B). CDAI does not include CRP or ESR and is a simple sum of SJC + TJC + EGA + PGA. Thus, the calculation of CDAI is solely based on joint scores, as well as patient's and doctor's general assessments. As seen in Fig. 7 , there is no "carpet-on-floor" area indicating that CDAI is closely and linearly related with either joint counts or general assessments. Therefore, moderate disease activity (CDAI ≤22), low disease activity (CDAI ≤10), or remission (CDAI ≤2.8) can be calculated upon any combination of the four variables, independent of any other confounding factors. Indeed, a mean variable value of 5.5, 2.5, and 0.7 or less is required to reach moderate, low disease activity, or remission, respectively.
Discussion
There has been continuous debate regarding the comparison and practical use of three different disease activity composite indices, DAS28, SDAI, and CDAI in RA. In 2005, Aletaha et al. [8] proposed that APRs added little to composite indices. This led to the development of CDAI, an index not containing ESR or CRP [6, 11, 12] .
As most published papers presented calculations, we wished to visualize the distribution of various components in the three composite indices by drawing 3D carpets and by also presenting some examples in tables.
Our data confirm that while APRs may be useful when calculating DAS28 or SDAI in RA patients with high or moderate disease activity, ESR and/or CRP may be confounders of these calculations in patients with low disease activity or in those in remission. When using DAS28, ESR values >54 and >19 mm/h or, similarly, when calculating Some groups have also suggested that composite indices, such as DAS28 or SDAI, may exert problems when used in remission or in LDA states [10, [12] [13] [14] . It is imperative to use proper tools to assess remission and LDA, as nowadays, according to the recent EULAR and treat-to-target recommendations, standard care as well as clinical trials should target these disease states [13, [15] [16] [17] [18] . Furthermore, remission has also been associated with radiographic progression, especially in patients with residual joint swelling [19] . Interestingly, as among biologics, tocilizumab may have outstanding suppressive effects on APR production, APR-containing composite measures may be very sensitive tools in this special setting [10] .
Very recently, Bentley et al. [11] developed a modified version of DAS28 (mDAS28) that also lacks APRs. Modified DAS28 showed substantial agreement with DAS28, SDAI, and CDAI. In conclusion, our visualization of RA disease activity carpets confirms that ESR and/or CRP may be significant confounding factors when assessing patients in remission or those with LDA.
